Many lessons still to learn about autosomal dominant polycystic kidney disease
- PMID: 37664187
- PMCID: PMC10471629
- DOI: 10.1007/s44162-023-00017-8
Many lessons still to learn about autosomal dominant polycystic kidney disease
Abstract
We are still learning the genetic basis for many rare diseases. Here we provide a commentary on the analysis of the genetic landscape of patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD), one of the most common genetic kidney diseases. Approaches including both phenotype first and genotype first allows some interesting and informative observations within this disease population. PKD1 and PKD2 are the most frequent genetic causes of ADPKD accounting for 78% and 15% respectively, whilst around 7-8% of cases have an alternative genetic diagnosis. These rarer forms include IFT140, GANAB, PKHD1, HNF1B, ALG8, and ALG9. Some previously reported likely pathogenic PKD1 and PKD2 alleles may have a reduced penetrance, or indeed may have been misclassified in terms of their pathogenicity. This recent data concerning all forms of ADPKD points to the importance of performing genetics tests in all families with a clinical diagnosis of ADPKD as well as those with more atypical cystic kidney appearances. Following allele identification, performing segregation analysis wherever possible remains vital so that we continue to learn about these important genetic causes of kidney failure.
Keywords: ADPKD; Penetrance; Prevalence; Rare Disease; Whole Exome Sequencing.
© Egyptian Medical Association 2023.
Conflict of interest statement
Competing interestsProfessor John Sayer is a co-author of this study and Editorial Board member of the journal. He was not involved in handling this manuscript during the review process. The rest of the authors have no conflict of interest to declare.
Figures

References
-
- Administration, U.S Food and Drug. Orphan drug act. In Public Law 97–414, edited by FDA. 2013.
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous